Company No: 15394690 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2025
		£
Current assets		81,834
Creditors: amounts falling due within one year		( 17,207)
Net current assets		64,627
Total assets less current liabilities		64,627
Accruals and deferred income		( 1,800)
Net assets		62,827
Capital and reserves		62,827

For the financial period ending 31 January 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Kernow Psychiatry Ltd (registered number: 15394690) were approved and authorised for issue by the director on 06 October 2025 and were signed on its behalf by:

Dr J Reid Director

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 15394690). The address of its registered office is Wellness Hub Falmouth, Falmouth Business Park, Bickland Water Road, Falmouth, TR11 4SZ, United Kingdom.

2. Employees

	2025
	Number
Monthly average number of persons employed by the Company during the financial period, including the director	-

3. Directors’ benefits: advances, credit and guarantees

Advances

An advance for Directors Loan Account was made to the director on 31 January 2025 for £64,639 (at interest rate of 2.25%). During the year £65,285 was advanced an £1,312 has been repaid. The outstanding balance is repayable on demand.